Stomach Cancer Secondary to Hematologic Diseases.
10.5230/jkgca.2007.7.4.237
- Author:
Ji Hoon KIM
1
;
Sung Bae JEE
;
Hoon HUH
;
Hyung Min CHIN
;
Wook KIM
;
Dong Wook KIM
;
Jong Wook LEE
;
Woo Sung MIN
;
Choon Choo KIM
;
Hae Myung JEON
Author Information
1. Department of Surgery, The Catholic University of Korea College of Medicine, Seoul, Korea. hmjeon@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Hematologic disease;
Leukemia;
Stomach cancer;
Secondary cancer
- MeSH:
Gastrectomy;
Hematologic Diseases*;
Humans;
Incidence;
Korea;
Leukemia;
Leukemia, Lymphoid;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
Mass Screening;
Medical Records;
Recurrence;
Stomach Neoplasms*;
Stomach*
- From:Journal of the Korean Gastric Cancer Association
2007;7(4):237-241
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Patients with hematologic diseases such as chronic myeloid leukemia (CML) or chronic lymphoid leukemia (CLL) are known to have an increased chance of acquiring a secondary neoplasm. Stomach cancer is one of the most common malignant diseases in Korea, and we investigated whether the incidence of secondary stomach cancer in patients with a hematologic disease increases, in order to determine if a more intensive screening program for detecting secondary gastric cancer was required. We also investigated the safety of performing a gastrectomy in hematologic disease patients. MATERIALS AND METHODS: From 1992 to 2006, the medical records of 8376 patients diagnosed with one of the six common hematologic diseases were reviewed. RESULTS: Nine secondary stomach cancers were found among the 8376 patients during the 15-year observation period. No surgical-related complications occurred, and there was no recurrence of stomach cancer if detected early. CONCLUSION: It seems that a more intensive screening program for detecting secondary gastric cancer in hematologic disease patients is not required, and surgery is not risky in these patients.
